Atlas Trials

MEDI4736 Or MEDI4736 + Tremelimumab In Surgically Resectable Malignant Pleural Mesothelioma

Clinical trial NCT02592551 · COMPLETED

Trial details

NCT number
NCT02592551
Sponsor
Baylor College of Medicine
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Mesothelioma
Start date
2016-05-11
Primary completion
2019-08-06
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.